Clinical Trial Update: Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores [NA]

View source ↗

Summary

Clinical trial update on belatacept for kidney transplant recipients with intermediate Maryland Aggregate Pathology Index (MAPI) scores. The study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Nulojix (belatacept)

Snippet

Sponsor: University of Maryland | Conditions: End-Stage Renal Disease | NA | Status: COMPLETED